Monoclonal antibodies against RANKL and sclerostin for myeloma-related bone disease: can they change the standard of care?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Monoclonal antibodies against RANKL and sclerostin for myeloma-related bone disease: can they change the standard of care?

Published:2019-07-16 Issue:8 Volume:12 Page:651-663
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Kleber Martina¹²,Ntanasis-Stathopoulos Ioannis³,Dimopoulos Meletios A.³,Terpos Evangelos³

Affiliation:

1. Division of Hematology, Department of Medicine, University Hospital Basel, Basel, Switzerland

2. Division of Internal Medicine, Department of Medicine, University Hospital Basel, Basel, Switzerland

3. Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2019.1640115

Reference120 articles.

1. Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2. Review of 1027 Patients With Newly Diagnosed Multiple Myeloma

3. International Myeloma Working Group Recommendations for the Treatment of Multiple Myeloma–Related Bone Disease

4. Prognostic variables for survival and skeletal complications in patients with multiple myeloma osteolytic bone disease

5. Facharzt-Thesauren: Erleichterung der Kodierung nach ICD-10-GM in der Praxis

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secondary Osteoporosis and Metabolic Bone Diseases;Journal of Clinical Medicine;2022-04-24

2. Recent therapeutic approaches in myeloma;Bone Cancer;2022

3. Metabolic Disorders in Multiple Myeloma;International Journal of Molecular Sciences;2021-10-22

4. Modern markers for evaluating bone disease in multiple myeloma (Review);Experimental and Therapeutic Medicine;2021-09-20

5. The Role of Marrow Microenvironment in the Growth and Development of Malignant Plasma Cells in Multiple Myeloma;International Journal of Molecular Sciences;2021-04-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3